- Home
- SOS vs BOLT Comparison
SOS vs BOLT Comparison
Compare SOS & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOS
- BOLT
- Stock Information
- Founded
- SOS 2004
- BOLT 2015
- Country
- SOS China
- BOLT United States
- Employees
- SOS N/A
- BOLT N/A
- Industry
- SOS Finance: Consumer Services
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- SOS Finance
- BOLT Health Care
- Exchange
- SOS Nasdaq
- BOLT Nasdaq
- Market Cap
- SOS 17.0M
- BOLT 16.8M
- IPO Year
- SOS 2017
- BOLT 2021
- Fundamental
- Price
- SOS $8.48
- BOLT $6.19
- Analyst Decision
- SOS
- BOLT Buy
- Analyst Count
- SOS 0
- BOLT 3
- Target Price
- SOS N/A
- BOLT $50.00
- AVG Volume (30 Days)
- SOS 62.3K
- BOLT 18.8K
- Earning Date
- SOS 05-15-2025
- BOLT 08-12-2025
- Dividend Yield
- SOS N/A
- BOLT N/A
- EPS Growth
- SOS N/A
- BOLT N/A
- EPS
- SOS N/A
- BOLT N/A
- Revenue
- SOS $231,424,000.00
- BOLT $3,638,000.00
- Revenue This Year
- SOS N/A
- BOLT N/A
- Revenue Next Year
- SOS N/A
- BOLT $24.14
- P/E Ratio
- SOS N/A
- BOLT N/A
- Revenue Growth
- SOS 150.42
- BOLT N/A
- 52 Week Low
- SOS $4.04
- BOLT $5.20
- 52 Week High
- SOS $15.51
- BOLT $15.60
- Technical
- Relative Strength Index (RSI)
- SOS 72.31
- BOLT 52.70
- Support Level
- SOS $6.06
- BOLT $5.68
- Resistance Level
- SOS $9.62
- BOLT $6.40
- Average True Range (ATR)
- SOS 0.62
- BOLT 0.30
- MACD
- SOS 0.29
- BOLT 0.09
- Stochastic Oscillator
- SOS 72.17
- BOLT 79.81
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.